Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  3. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  4. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  5. Sefik E, et al. 2022. Nature. 606:585. PubMed
  6. Leinroth AP, et al. 2022. Cell Rep. 39:110785. PubMed
  7. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  8. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  9. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  10. Tao X, et al. 2022. EMBO J. 41:e110439. PubMed
  11. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  12. Li X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1077. PubMed
  13. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  14. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  15. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  16. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  17. Zheng Z, et al. 2022. Cells. 11: . PubMed
  18. Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed
  19. Varshney R, et al. 2023. iScience. 26:105750. PubMed
  20. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  21. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  22. Chen L, et al. 2023. Bioeng Transl Med. 8:e10377. PubMed
  23. Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed
  24. Zhao Y, et al. 2023. Sci Adv. 9:eabo1360. PubMed
  25. Liu X, et al. 2022. Pain. 163:508. PubMed
  26. González H, et al. 2022. Cell. 185:729. PubMed
  27. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  28. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  29. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  30. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  31. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  32. Pfeifhofer-Obermair C, et al. 2022. Bio Protoc. 12:e4378. PubMed
  33. Hanuscheck N, et al. 2022. J Exp Med. 219:. PubMed
  34. Klawitter M, et al. 2022. Int J Mol Sci. 23:. PubMed
  35. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  36. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  37. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  38. Zhang Y, et al. 2023. Invest Ophthalmol Vis Sci. 64:1. PubMed
  39. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  40. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  41. Li M, et al. 2023. Front Immunol. 14:1087923. PubMed
  42. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  43. Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed
  44. Volkova MV, et al. 2023. Int J Mol Sci. 24:. PubMed
  45. Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed
  46. Li L, et al. 2023. iScience. 26:106095. PubMed
  47. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  48. Xu H, et al. 2023. Acta Pharm Sin B. 13:678. PubMed
  49. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  50. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  51. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  52. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  53. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  54. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  55. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  56. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  57. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  58. Wang X, et al. 2023. Nature. 618:808. PubMed
  59. Akasaka H, et al. 2023. JCI Insight. 8:. PubMed
  60. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  61. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  62. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  63. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  64. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  65. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  66. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  67. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  68. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  69. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  70. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  71. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  72. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  73. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  74. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  75. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  76. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  77. Zhu H, et al. 2018. Elife. 7:. PubMed
  78. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  79. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  80. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  81. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  82. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  83. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  84. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  85. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  86. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  87. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  88. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  89. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  90. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  91. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  92. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  93. Saito S, et al. 2020. Nutrients. 12:. PubMed
  94. Liu X, et al. 2020. Nature. . PubMed
  95. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  96. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  97. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  98. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  99. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  100. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  101. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  102. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  103. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  104. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  105. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  106. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  107. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  108. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  109. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  110. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  111. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  112. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  113. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  114. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  115. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  116. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  117. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  118. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  119. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  120. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  121. Plein A, et al. 2018. Nature. 562:223. PubMed
  122. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  123. Green DP, et al. 2019. Neuron. 101:412. PubMed
  124. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  125. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  126. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  127. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  128. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  129. Zhang X, et al. 2022. Cells. 11:. PubMed
  130. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  131. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  132. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  133. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  134. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  135. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  136. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  137. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  138. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  139. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  140. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  141. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  142. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  143. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  144. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  145. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  146. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  147. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  148. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  149. Li J, et al. 2020. Elife. 9:00. PubMed
  150. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  151. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  152. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  153. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  154. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  155. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  156. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  157. Wan X, et al. 2018. Nature. 560:107. PubMed
  158. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  159. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  160. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  161. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  162. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  163. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  164. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  165. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  166. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  167. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  168. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  169. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  170. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  171. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  172. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  173. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  174. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  175. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  176. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  177. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  178. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  179. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  180. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  181. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  182. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  183. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  184. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  185. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  186. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  187. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  188. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  189. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  190. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  191. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  192. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  193. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  194. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  195. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  196. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  197. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  198. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  199. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  200. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  201. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  202. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  203. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  204. Long JT, et al. 2022. Elife. 11:. PubMed
  205. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  206. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  207. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  208. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  209. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  210. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  211. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  212. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  213. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  214. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  215. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  216. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  217. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  218. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  219. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  220. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  221. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  222. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  223. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  224. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  225. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  226. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  227. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  228. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  229. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  230. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  231. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  232. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  233. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  234. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  235. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  236. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  237. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  238. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  239. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  240. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  241. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  242. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  243. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  244. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  245. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  246. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  247. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  248. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  249. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  250. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  251. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  252. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  254. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  255. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  256. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  257. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  258. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  259. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  260. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  261. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  262. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  263. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  264. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  265. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  266. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  267. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  268. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  269. Sheng J, et al. 2021. eLife. 10:00. PubMed
  270. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  271. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  272. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  273. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  274. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  275. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  276. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  277. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  278. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  279. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  280. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  281. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  282. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  283. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  284. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  285. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  286. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  287. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  288. Dingler FA, et al. 2020. Mol Cell. . PubMed
  289. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  290. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account